Research / ACA / Fundamental state Inspectable configuration
State dimensions Filing 0001739445-26-000126 General Corporate
Debt relative to revenue 85th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.debt_to_revenue
216.94% · OPTIONAL · VALID
Capex intensity 90th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.capex_revenue_ratio
8.93% · OPTIONAL · VALID
Operating cash generation 0th Own-history percentile · N=20
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-1.70% · OPTIONAL · VALID
Revenue growth 0th Own-history percentile · N=20
Evidence method Yoy · gp.fundamentals.revenue
-10.61% · CORE · VALID
Inventory pressure 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.inventory_revenue_ratio
55.29% · OPTIONAL · VALID
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
23.64% · CORE · NOT_ENOUGH_HISTORY
Operating margin 80th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.operating_margin
12.80% · CORE · VALID
SBC intensity 45th Own-history percentile · N=20
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
0.91% · OPTIONAL · VALID
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 28 states Self-history eligible
Sep 30, 2021 7/7 normalized Level 3 Dec 31, 2021 7/7 normalized Level 3 Mar 31, 2022 7/7 normalized Level 3 Jun 30, 2022 7/7 normalized Level 3 Sep 30, 2022 7/7 normalized Level 3 Dec 31, 2022 7/7 normalized Level 3 Mar 31, 2023 7/7 normalized Level 3 Jun 30, 2023 7/7 normalized Level 3 Sep 30, 2023 7/7 normalized Level 3 Dec 31, 2023 7/7 normalized Level 3 Mar 31, 2024 7/7 normalized Level 3 Jun 30, 2024 7/7 normalized Level 3 Sep 30, 2024 7/7 normalized Level 3 Dec 31, 2024 7/7 normalized Level 3 Mar 31, 2025 7/7 normalized Level 3 Jun 30, 2025 7/8 normalized Level 3 Sep 30, 2025 7/8 normalized Level 3 Dec 31, 2025 7/8 normalized Level 3 Mar 31, 2026 7/8 normalized Level 3 Jun 30, 2026 7/8 normalized Level 4 Period transition
What moved in the state? Balance Sheet Leverage Decreased
Previous 264.67%
Current 216.94%
Delta -47.72% Capex Intensity Increased
Previous 7.61%
Current 8.93%
Delta 1.32% Cash Generation Decreased
Previous 12.58%
Current -1.70%
Delta -14.28% Growth Decreased
Previous -9.54%
Current -10.61%
Delta -1.07% Inventory Pressure Decreased
Previous 61.22%
Current 55.29%
Delta -5.93% Margin Increased
Previous 21.15%
Current 23.64%
Delta 2.49% Profitability Increased
Previous 8.24%
Current 12.80%
Delta 4.56% Sbc Intensity Decreased
Previous 1.10%
Current 0.91%
Delta -0.19% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Mar 31, 2023
Similarity 82%
Compared 7 dimensions
Coverage 100% Growth 7.1 · Profitability 14.4 · Sbc Intensity 32.8 · Capex Intensity 10.0 · Cash Generation 23.5 · Inventory Pressure 0.6 · Balance Sheet Leverage 12.8 Sep 30, 2023
Similarity 79%
Compared 7 dimensions
Coverage 100% Growth 12.5 · Profitability 35.0 · Sbc Intensity 25.0 · Capex Intensity 4.7 · Cash Generation 26.3 · Inventory Pressure 5.0 · Balance Sheet Leverage 20.0 Mar 31, 2025
Similarity 76%
Compared 7 dimensions
Coverage 100% Growth 35.0 · Profitability 20.0 · Sbc Intensity 30.0 · Capex Intensity 35.0 · Cash Generation 0.0 · Inventory Pressure 5.0 · Balance Sheet Leverage 15.0 Sep 30, 2022
Similarity 73%
Compared 7 dimensions
Coverage 100% Growth 25.0 · Profitability 30.0 · Sbc Intensity 17.5 · Capex Intensity 10.0 · Cash Generation 53.3 · Inventory Pressure 13.8 · Balance Sheet Leverage 10.0 Jun 30, 2024
Similarity 68%
Compared 7 dimensions
Coverage 100% Growth 63.2 · Profitability 10.0 · Sbc Intensity 45.0 · Capex Intensity 15.0 · Cash Generation 25.0 · Inventory Pressure 10.0 · Balance Sheet Leverage 10.0 Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.